KRT88P and cancer: The frequency of positive anti-HBc was observed in cancer patients with breast 1/27 (3.7%), Rectal 2/17 (11.7%), Cervix 2/9 (22.2%), Prostate 1/8 (12.5%) and lung 2/2 (100%) cases.